FY ended March 2021

• Japan: Sales increased 2.2%. Nihon Kohden concentrated on enhancing sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. The Company also focused on selling in-house products as well as strengthening its marketing and service capabilities, creating customer value which contributed to improving medical safety, patient outcomes, and operating efficiency. As a result of these initiatives, sales increased. The Government’s supplementary budget has supported demand in healthcare systems for accepting COVID-19 patients towards the end of the fiscal year due to the third wave of COVID-19 from November 2020, while medical institutions reduced the number of testing and surgical procedures, and postponed or froze the purchase budget for certain products. Sales in the public hospital and private hospital markets increased favorably. Sales of AEDs in the PAD market also showed strong growth. In the university hospital market, there was a reactionary decline compared to FY2019 when sales were strong due to large orders related to construction of new hospitals. Sales in the clinic market also decreased.
• International: Sales increased 23.3%. Sales in all regions achieved double-digit growth because demand for patient monitors, ventilators and defibrillators increased due to the spread of COVID-19.

• Americas: Sales increased 22.5%. Sales in both the U.S. and Latin America showed double-digit growth. Especially, sales in Mexico and Colombia achieved 200% growth.
• Europe: Sales increased 45.3%. Sales both in Western Europe and Eastern Europe showed strong growth, supported by 200% growth in Italy and Poland.  
• Asia & Other: Sales increased 12.7%. Sales increased favorably, thanks to large orders in Israel and Indonesia. Sales in China increased steadily as the impact of COVID-19 had ended.